Search results
5 stocks to watch on Friday: XOM, CVX, ABBV and more
Seeking Alpha· 3 days agoExxon Mobil (XOM), Chevron (CVX), AbbVie (ABBV), Skechers (SKX) and Atlassian (TEAM) are the stocks to watch on Friday.
AbbVie Lifts 2024 Forecast as Newer Drugs Replace Humira Losses
Bloomberg· 3 days agoAbbVie Inc. lifted its full-year profit guidance as newer anti-inflammatory treatments like Rinvoq...
AbbVie Reports First-Quarter 2024 Financial Results
Tri-County Times· 3 days agoReports First-Quarter Diluted EPS of $0.77 on a GAAP Basis, an Increase of 492.3 Percent; Adjusted Diluted EPS of $2.31, a Decrease of 6.1 Percent; These Results Include an Unfavorable
Zacks Industry Outlook Highlights Eli Lilly, Novo Nordisk, Merck and AbbVie
Zacks via Yahoo Finance· 4 days agoNewer immunology medicines, Skyrizi and Rinvoq, are performing extremely well, bolstered by approval...
Gear Up for AbbVie (ABBV) Q1 Earnings: Wall Street Estimates for Key Metrics
Zacks via Yahoo Finance· 6 days agoGet a deeper insight into the potential performance of AbbVie (ABBV) for the quarter ended March...
AbbVie’s first-quarter results top expectations as arthritis drugs fuel growth
Market Watch· 3 days agoAbbVie Inc. on Friday reported first-quarter results that beat expectations, even as sales of...
Nvidia will soar 21% to $1,000 as its new AI chip slams would-be rivals, Morgan Stanley says. It’s...
Fortune via Yahoo Finance· 5 days ago“We believe that growth from ABBV’s ex-Humira business (primarily Skyrizi, Rinvoq, and aesthetics)...
4 Large Drug Stocks to Hold on to Amid Industry Challenges
Zacks via Yahoo Finance· 5 days agoDrug and biotech companies are likely to see significant innovation. In the Large-Cap...
AbbVie's newer drugs are offsetting losses of the world's once best-selling medication
Quartz· 3 days agoSales of the pharma giant's newer drugs are offsetting its Humira losses.
CPAP Stock Rockets As Quarterly Report Wipes Out Weight-Loss Woes
Investor's Business Daily· 3 days agoResMed is the biggest maker of CPAPs in the U.S., and says the growing popularity of weight-loss...